$RVTY
REVVITY, INC.

2023 Q3 Form 10-Q Financial Statement

#000003179123000011 Filed on August 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2022 Q3
Revenue $709.1M $1.230B
YoY Change -42.33% 0.09%
Cost Of Revenue $306.7M $563.4M
YoY Change -45.56% 3.71%
Gross Profit $402.3M $666.2M
YoY Change -39.6% -2.78%
Gross Profit Margin 56.74% 54.18%
Selling, General & Admin $267.0M $308.1M
YoY Change -13.34% 9.33%
% of Gross Profit 66.37% 46.25%
Research & Development $57.25M $73.35M
YoY Change -21.95% 11.44%
% of Gross Profit 14.23% 11.01%
Depreciation & Amortization $108.9M $119.4M
YoY Change -8.77% 57.9%
% of Gross Profit 27.07% 17.92%
Operating Expenses $324.3M $381.5M
YoY Change -14.99% 9.73%
Operating Profit $78.06M $284.7M
YoY Change -72.58% -14.38%
Interest Expense -$2.984M -$23.46M
YoY Change -87.28% -240.04%
% of Operating Profit -3.82% -8.24%
Other Income/Expense, Net -$3.518M -$2.930M
YoY Change 20.07% -54.44%
Pretax Income $71.55M $224.5M
YoY Change -68.12% -31.16%
Income Tax $12.93M $45.22M
% Of Pretax Income 18.07% 20.15%
Net Earnings $35.56M $179.2M
YoY Change -80.16% -27.13%
Net Earnings / Revenue 5.01% 14.58%
Basic Earnings Per Share $0.28 $1.42
Diluted Earnings Per Share $0.28 $1.417M
COMMON SHARES
Basic Shares Outstanding 125.2M shares 126.1M shares
Diluted Shares Outstanding 125.4M shares 126.5M shares

Balance Sheet

Concept 2023 Q3 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.071B $360.9M
YoY Change 473.9% -37.0%
Cash & Equivalents $1.332B $360.9M
Short-Term Investments $739.1M
Other Short-Term Assets $388.6M $190.5M
YoY Change 104.02% 5.15%
Inventory $436.8M $624.3M
Prepaid Expenses
Receivables $626.9M $932.1M
Other Receivables $0.00 $0.00
Total Short-Term Assets $3.523B $2.108B
YoY Change 67.16% -6.74%
LONG-TERM ASSETS
Property, Plant & Equipment $658.0M $743.0M
YoY Change -11.44% 96.0%
Goodwill $6.518B
YoY Change
Intangibles $3.197B
YoY Change
Long-Term Investments
YoY Change
Other Assets $321.6M $324.2M
YoY Change -0.83% -33.32%
Total Long-Term Assets $10.70B $12.08B
YoY Change -11.48% 86.46%
TOTAL ASSETS
Total Short-Term Assets $3.523B $2.108B
Total Long-Term Assets $10.70B $12.08B
Total Assets $14.22B $14.19B
YoY Change 0.2% 62.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $235.7M $333.7M
YoY Change -29.36% 2.77%
Accrued Expenses $652.2M $705.9M
YoY Change -7.61% -11.03%
Deferred Revenue $19.85M
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $478.9M $4.180M
YoY Change 11357.8% -10.47%
Total Short-Term Liabilities $1.367B $1.044B
YoY Change 30.95% -7.04%
LONG-TERM LIABILITIES
Long-Term Debt $3.884B $4.484B
YoY Change -13.39% 90.94%
Other Long-Term Liabilities $1.098B $1.494B
YoY Change -26.53% 78.13%
Total Long-Term Liabilities $4.982B $5.979B
YoY Change -16.68% 87.57%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.367B $1.044B
Total Long-Term Liabilities $4.982B $5.979B
Total Liabilities $6.349B $7.023B
YoY Change -9.6% 56.07%
SHAREHOLDERS EQUITY
Retained Earnings $5.539B
YoY Change
Common Stock $2.636B
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $7.870B $7.167B
YoY Change
Total Liabilities & Shareholders Equity $14.22B $14.19B
YoY Change 0.2% 62.36%

Cashflow Statement

Concept 2023 Q3 2022 Q3
OPERATING ACTIVITIES
Net Income $35.56M $179.2M
YoY Change -80.16% -27.13%
Depreciation, Depletion And Amortization $108.9M $119.4M
YoY Change -8.77% 57.9%
Cash From Operating Activities -$135.3M $97.49M
YoY Change -238.81% -66.13%
INVESTING ACTIVITIES
Capital Expenditures $13.95M -$23.15M
YoY Change -160.24% 13.64%
Acquisitions
YoY Change
Other Investing Activities -$557.1M -$5.201M
YoY Change 10611.25% -98.07%
Cash From Investing Activities -$571.0M -$28.36M
YoY Change 1913.9% -90.22%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net -$209.0M $3.988M
YoY Change -5339.49%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -228.3M -354.6M
YoY Change -35.63% 37.59%
NET CHANGE
Cash From Operating Activities -135.3M 97.49M
Cash From Investing Activities -571.0M -28.36M
Cash From Financing Activities -228.3M -354.6M
Net Change In Cash -934.6M -285.5M
YoY Change 227.39% 9.86%
FREE CASH FLOW
Cash From Operating Activities -$135.3M $97.49M
Capital Expenditures $13.95M -$23.15M
Free Cash Flow -$149.3M $120.6M
YoY Change -223.73% -60.86%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.07
CY2022Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.07
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.07
CY2023Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.07
CY2023Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.07
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
7141245000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
176962000 usd
CY2022Q2 pki Other Comprehensive Income Lossafter Reclassifications Netof Tax
OtherComprehensiveIncomeLossafterReclassificationsNetofTax
-84027000 usd
CY2022Q2 us-gaap Dividends
Dividends
8905000 usd
CY2022Q2 pki Stock Issued During Period Value Stock Options Exercised And Related Income Tax Benefit
StockIssuedDuringPeriodValueStockOptionsExercisedAndRelatedIncomeTaxBenefit
1397000 usd
CY2022Q2 pki Cost Of Repurchased Common Shares Repurchase Plan And Amount For Statutory Tax Withholding Obligations
CostOfRepurchasedCommonSharesRepurchasePlanAndAmountForStatutoryTaxWithholdingObligations
55592000 usd
CY2022Q2 pki Issuance Of Common Stock For Long Term Incentive Program
IssuanceOfCommonStockForLongTermIncentiveProgram
12470000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2792000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1826000 usd
CY2022Q3 pki Cost Of Repurchased Common Shares Repurchase Plan And Amount For Statutory Tax Withholding Obligations
CostOfRepurchasedCommonSharesRepurchasePlanAndAmountForStatutoryTaxWithholdingObligations
456000 usd
CY2022Q3 pki Issuance Of Common Stock For Long Term Incentive Program
IssuanceOfCommonStockForLongTermIncentiveProgram
12272000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3758000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
7167155000 usd
us-gaap Net Income Loss
NetIncomeLoss
605034000 usd
us-gaap Net Income Loss
NetIncomeLoss
356174000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
521567000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
10503000 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
83467000 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
345671000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
23526000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
29665000 usd
pki Restructuring Chargesand Changesin Estimates
RestructuringChargesandChangesinEstimates
-5104000 usd
pki Restructuring Chargesand Changesin Estimates
RestructuringChargesandChangesinEstimates
-12669000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
217938000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
218030000 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1085000 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1363000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3818000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3852000 usd
pki Change In Fair Value Of Financial Securities
ChangeInFairValueOfFinancialSecurities
745000 usd
pki Change In Fair Value Of Financial Securities
ChangeInFairValueOfFinancialSecurities
-9215000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
3345000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-488000 usd
pki Foreign Exchange Gains Losses Related To Proceed From Sale Of Business
ForeignExchangeGainsLossesRelatedToProceedFromSaleOfBusiness
23679000 usd
pki Foreign Exchange Gains Losses Related To Proceed From Sale Of Business
ForeignExchangeGainsLossesRelatedToProceedFromSaleOfBusiness
0 usd
pki Amortization Of Acquired Inventory Revaluation
AmortizationOfAcquiredInventoryRevaluation
0 usd
pki Amortization Of Acquired Inventory Revaluation
AmortizationOfAcquiredInventoryRevaluation
33724000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
10216000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-80334000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
26775000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
31794000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-49225000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-9661000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-240285000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-270206000 usd
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
28026000 usd
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
423350000 usd
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-99882000 usd
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-42650000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-71856000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
380700000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
34895000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
46472000 usd
pki Purchases Of Investments
PurchasesOfInvestments
5000000 usd
pki Purchases Of Investments
PurchasesOfInvestments
22250000 usd
pki Purchases Of Marketable Securities
PurchasesOfMarketableSecurities
831219000 usd
pki Purchases Of Marketable Securities
PurchasesOfMarketableSecurities
0 usd
pki Proceeds From Marketable Securities
ProceedsFromMarketableSecurities
100000000 usd
pki Proceeds From Marketable Securities
ProceedsFromMarketableSecurities
0 usd
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
0 usd
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
1054000 usd
pki Payments For Acquisitions And Investments Net Of Cash And Cash Equivalents Acquired
PaymentsForAcquisitionsAndInvestmentsNetOfCashAndCashEquivalentsAcquired
686000 usd
pki Payments For Acquisitions And Investments Net Of Cash And Cash Equivalents Acquired
PaymentsForAcquisitionsAndInvestmentsNetOfCashAndCashEquivalentsAcquired
5635000 usd
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-771800000 usd
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-73303000 usd
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
2065261000 usd
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
-11358000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1293461000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-84661000 usd
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
0 usd
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
220000000 usd
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
0 usd
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
220000000 usd
us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
0 usd
us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
450000000 usd
us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
50835000 usd
us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
0 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
15000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
us-gaap Proceeds From Repayments Of Other Debt
ProceedsFromRepaymentsOfOtherDebt
7231000 usd
us-gaap Proceeds From Repayments Of Other Debt
ProceedsFromRepaymentsOfOtherDebt
-825000 usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
10117000 usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
5000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3215000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5841000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
273299000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
56048000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
17638000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
17667000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-341458000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-519466000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-17571000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-33977000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
862576000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-257404000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
470746000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
619337000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1333322000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
361933000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1331903000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
345861000 usd
CY2023Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
1062000 usd
CY2022Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
1073000 usd
CY2023Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
357000 usd
CY2022Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
0 usd
CY2023Q3 us-gaap Disposal Group Including Discontinued Operation Cash And Cash Equivalents
DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
0 usd
CY2022Q3 us-gaap Disposal Group Including Discontinued Operation Cash And Cash Equivalents
DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
14999000 usd
us-gaap Other Significant Noncash Transaction Value Of Consideration Received1
OtherSignificantNoncashTransactionValueOfConsiderationReceived1
261317000 usd
us-gaap Other Significant Noncash Transaction Value Of Consideration Received1
OtherSignificantNoncashTransactionValueOfConsiderationReceived1
0 usd
us-gaap Basis Of Accounting
BasisOfAccounting
Basis of Presentation<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements included herein have been prepared by Revvity, Inc. (formerly PerkinElmer, Inc.) (the “Company”), in accordance with accounting principles generally accepted in the United States of America (the “U.S.” or the “United States”) and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information in the footnote disclosures of the financial statements has been condensed or omitted where it substantially duplicates information provided in the Company’s latest audited consolidated financial statements, in accordance with the rules and regulations of the SEC. These condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and notes included in its Annual Report on Form 10-K for the fiscal year ended January 1, 2023, filed with the SEC (the “2022 Form 10-K”). The balance sheet amounts at January 1, 2023 in this report were derived from the Company’s audited 2022 consolidated financial statements included in the 2022 Form 10-K. The condensed consolidated financial statements reflect all adjustments that, in the opinion of management, are necessary to present fairly the Company’s financial position, results of operations and cash flows for the periods indicated. The preparation of financial statements in conformity with U.S. Generally Accepted Accounting Principles requires management to make estimates and assumptions that affect the reported amounts and classifications of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The results of operations for the three and six months ended July 2, 2023 and July 3, 2022, respectively, are not necessarily indicative of the results for the entire fiscal year or any future period. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2023, the Company completed the previously announced sale of certain assets and the equity interests of certain entities constituting the Company’s Applied, Food and Enterprise Services businesses (the “Business”). </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Business is reported for all pe</span>riods as discontinued operations in the Company’s consolidated financial statements.
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
709066000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
895642000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
709066000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
895642000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1383931000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1858805000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1383931000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1858805000 usd
CY2023Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
61571000 usd
CY2023Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
56631000 usd
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
19850000 usd
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
30133000 usd
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
25046000 usd
CY2022Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
762000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
30318000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
1357000 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
26007000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
27128000 usd
us-gaap Interest Expense
InterestExpense
48745000 usd
us-gaap Interest Expense
InterestExpense
55516000 usd
CY2023Q3 pki Change In Fair Value Of Financial Securities
ChangeInFairValueOfFinancialSecurities
-2023000 usd
CY2022Q3 pki Change In Fair Value Of Financial Securities
ChangeInFairValueOfFinancialSecurities
2909000 usd
pki Change In Fair Value Of Financial Securities
ChangeInFairValueOfFinancialSecurities
745000 usd
pki Change In Fair Value Of Financial Securities
ChangeInFairValueOfFinancialSecurities
-9215000 usd
CY2023Q3 pki Other Components Of Net Periodic Pension Cost Credit
OtherComponentsOfNetPeriodicPensionCostCredit
-2286000 usd
CY2022Q3 pki Other Components Of Net Periodic Pension Cost Credit
OtherComponentsOfNetPeriodicPensionCostCredit
2561000 usd
pki Other Components Of Net Periodic Pension Cost Credit
OtherComponentsOfNetPeriodicPensionCostCredit
-4475000 usd
pki Other Components Of Net Periodic Pension Cost Credit
OtherComponentsOfNetPeriodicPensionCostCredit
5116000 usd
CY2023Q3 pki Foreign Exchange Losses And Other Expense Income Net
ForeignExchangeLossesAndOtherExpenseIncomeNet
1232000 usd
CY2022Q3 pki Foreign Exchange Losses And Other Expense Income Net
ForeignExchangeLossesAndOtherExpenseIncomeNet
5254000 usd
pki Foreign Exchange Losses And Other Expense Income Net
ForeignExchangeLossesAndOtherExpenseIncomeNet
31024000 usd
pki Foreign Exchange Losses And Other Expense Income Net
ForeignExchangeLossesAndOtherExpenseIncomeNet
4944000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6502000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-26150000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-53181000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-63202000 usd
CY2023Q3 pki Foreign Exchange Gains Losses Related To Proceed From Sale Of Business
ForeignExchangeGainsLossesRelatedToProceedFromSaleOfBusiness
-2400000 usd
pki Foreign Exchange Gains Losses Related To Proceed From Sale Of Business
ForeignExchangeGainsLossesRelatedToProceedFromSaleOfBusiness
23700000 usd
CY2023Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
204189000 usd
CY2023Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
190640000 usd
CY2023Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
74206000 usd
CY2023Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
68206000 usd
CY2023Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
158427000 usd
CY2023Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
146616000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
436822000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
405462000 usd
CY2023Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
3914547000 usd
CY2023Q3 pki Current Portion Of Long Term Debt Gross
CurrentPortionOfLongTermDebtGross
479205000 usd
CY2023Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
478936000 usd
CY2023Q3 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
4393752000 usd
CY2023Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
5446000 usd
CY2023Q3 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
25632000 usd
CY2023Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
3957257000 usd
CY2023Q1 pki Current Portion Of Long Term Debt Gross
CurrentPortionOfLongTermDebtGross
471859000 usd
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
470929000 usd
CY2023Q1 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
4429116000 usd
CY2023Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
6020000 usd
CY2023Q1 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
28820000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
125215000 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
126126000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
125745000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
126132000 shares
CY2023Q3 pki Incremental Common Shares Attributable To Share Based Payment Arrangements Stock Options
IncrementalCommonSharesAttributableToShareBasedPaymentArrangementsStockOptions
123000 shares
CY2022Q3 pki Incremental Common Shares Attributable To Share Based Payment Arrangements Stock Options
IncrementalCommonSharesAttributableToShareBasedPaymentArrangementsStockOptions
259000 shares
pki Incremental Common Shares Attributable To Share Based Payment Arrangements Stock Options
IncrementalCommonSharesAttributableToShareBasedPaymentArrangementsStockOptions
136000 shares
pki Incremental Common Shares Attributable To Share Based Payment Arrangements Stock Options
IncrementalCommonSharesAttributableToShareBasedPaymentArrangementsStockOptions
316000 shares
CY2023Q3 pki Incremental Common Shares Attributable To Share Based Payments Arrangements Restricted Stock Awards
IncrementalCommonSharesAttributableToShareBasedPaymentsArrangementsRestrictedStockAwards
60000 shares
CY2022Q3 pki Incremental Common Shares Attributable To Share Based Payments Arrangements Restricted Stock Awards
IncrementalCommonSharesAttributableToShareBasedPaymentsArrangementsRestrictedStockAwards
124000 shares
pki Incremental Common Shares Attributable To Share Based Payments Arrangements Restricted Stock Awards
IncrementalCommonSharesAttributableToShareBasedPaymentsArrangementsRestrictedStockAwards
37000 shares
pki Incremental Common Shares Attributable To Share Based Payments Arrangements Restricted Stock Awards
IncrementalCommonSharesAttributableToShareBasedPaymentsArrangementsRestrictedStockAwards
133000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
125398000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
126509000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
125918000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
126581000 shares
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
767000 shares
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
662000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
766000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
627000 shares
CY2023Q3 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segments
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
78056000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
232494000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
154175000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
494450000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6502000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-26150000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-53181000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-63202000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
71554000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
206344000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
100994000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
431248000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-304436000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-446664000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax
AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
798000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax
AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
798000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
262000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-35000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-304972000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-447497000 usd
CY2023Q3 pki Repurchased Common Shares For Activity Pursuantto Equity Incentive Plans
RepurchasedCommonSharesForActivityPursuanttoEquityIncentivePlans
3750 shares
CY2023Q3 pki Aggregate Costof Repurchased Common Sharesfor Activity Pursuantto Equity Incentive Plans
AggregateCostofRepurchasedCommonSharesforActivityPursuanttoEquityIncentivePlans
500000 usd
pki Repurchased Common Shares For Activity Pursuantto Equity Incentive Plans
RepurchasedCommonSharesForActivityPursuanttoEquityIncentivePlans
69743 shares
pki Aggregate Costof Repurchased Common Sharesfor Activity Pursuantto Equity Incentive Plans
AggregateCostofRepurchasedCommonSharesforActivityPursuanttoEquityIncentivePlans
9500000 usd
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.07
CY2023Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
8700000 usd
CY2023Q3 us-gaap Dividends Payable Date Declared Day Month And Year
DividendsPayableDateDeclaredDayMonthAndYear
2023-04-25
CY2023Q1 pki Impairment Testing Date
ImpairmentTestingDate
January 2, 2023
CY2023Q1 us-gaap Goodwill
Goodwill
6481768000 usd
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
36651000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
6518419000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3197230000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3377174000 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
92800000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
184600000 usd
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
93700000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
188900000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
179800000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
357100000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
336200000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
328600000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
301100000 usd
pki Percentage Of Business Outside Domestic Country
PercentageOfBusinessOutsideDomesticCountry
0.60
CY2023Q3 us-gaap Interest Rate Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months Net
InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
0 usd
CY2023Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
15930000 usd
CY2023Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
0 usd
CY2023Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
0 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
15930000 usd
CY2023Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease
0 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease
0 usd
CY2023Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
15930000 usd
CY2023Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
0 usd
CY2022Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
0 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
0 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
-4961000 usd
CY2023Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
8718000 usd
CY2022Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
1904000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
10142000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
3326000 usd
CY2023Q3 pki Fair Value Measurement With Unobservable Inputs Reconciliation Adjustments Recognized In Goodwill
FairValueMeasurementWithUnobservableInputsReconciliationAdjustmentsRecognizedInGoodwill
0 usd
CY2022Q3 pki Fair Value Measurement With Unobservable Inputs Reconciliation Adjustments Recognized In Goodwill
FairValueMeasurementWithUnobservableInputsReconciliationAdjustmentsRecognizedInGoodwill
0 usd
pki Fair Value Measurement With Unobservable Inputs Reconciliation Adjustments Recognized In Goodwill
FairValueMeasurementWithUnobservableInputsReconciliationAdjustmentsRecognizedInGoodwill
0 usd
pki Fair Value Measurement With Unobservable Inputs Reconciliation Adjustments Recognized In Goodwill
FairValueMeasurementWithUnobservableInputsReconciliationAdjustmentsRecognizedInGoodwill
12400000 usd
CY2023Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
2445000 usd
CY2022Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
669000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
1085000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
1362000 usd
CY2023Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
37561000 usd
CY2022Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
48593000 usd
CY2023Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
37561000 usd
CY2022Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
48593000 usd
CY2023Q3 us-gaap Accrual For Environmental Loss Contingencies
AccrualForEnvironmentalLossContingencies
13500000 usd
CY2023Q1 us-gaap Accrual For Environmental Loss Contingencies
AccrualForEnvironmentalLossContingencies
12200000 usd
pki Number Of Years Over Which Estimated Environmental Cost Will Be Paid
NumberOfYearsOverWhichEstimatedEnvironmentalCostWillBePaid
10 years
CY2023Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000031791-23-000011-index-headers.html Edgar Link pending
0000031791-23-000011-index.html Edgar Link pending
0000031791-23-000011.txt Edgar Link pending
0000031791-23-000011-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pki-20230702.htm Edgar Link pending
pki-20230702.xsd Edgar Link pending
pki-20230702_cal.xml Edgar Link unprocessable
pki-20230702_def.xml Edgar Link unprocessable
pki-20230702_lab.xml Edgar Link unprocessable
pki-20230702_htm.xml Edgar Link completed
q2-202310qexhibit101.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rvty-07022023xex_311.htm Edgar Link pending
rvty-07022023xex_312.htm Edgar Link pending
rvty-07022023xex_321.htm Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
pki-20230702_pre.xml Edgar Link unprocessable